We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Duraplasty Graft Seals Cerebrospinal Fluid Leaks

By HospiMedica International staff writers
Posted on 17 Mar 2014
A new treatment option is now available for the repair the dura mater following cerebrospinal fluid (CSF) leaks at the base of the skull. 

The Biodesign Duraplasty Graft is a non-dermis, non-cross-linked biologic graft that is designed for repairs of the dura mater, the thick membrane that is the outermost of the three layers of the meninges that surround the brain and spinal cord, and is responsible for keeping in the CSF; it is derived from mesoderm. More...
The Biodesign graft itself is derived from a natural material that is easy to manipulate, does not swell with hydration, and does not fold onto itself. Once in place, the body completely remodels the graft into strong, well-vascularized tissue. 

The graft can be placed with or without sutures and it can achieve a strong seal, so that it provides a well-balanced treatment option. It can also be used to treat existing CSF leaks, such as those resulting from trauma or sinus surgery at the skull base. Another benefit of Biodesign graft is that it reduces the need to harvest tissue from other parts of the body for use in the repair. The Biodesign Duraplasty Graft is a product of Cook Medical (Bloomington, IN, USA), and has been approved by the US Food and Drug Administration (FDA).

“Biodesign’s proven tissue repair technology works in different grafting procedures,” said Thomas Cherry, RN, OHNS global leader of the Cook Medical Otolaryngology – Head and Neck Surgery (OHNS) clinical division. “We’re excited to introduce the device to otolaryngologists and expand OHNS’s Biodesign line. Because of Biodesign’s excellent handling characteristics, physicians can secure the Biodesign graft during skull-base dura mater reconstruction with or without suturing.”

“I started using Biodesign because I found it easier to handle during the endoscopic repair than competing products,” said Bradford Woodworth, MD, director of otolaryngology research at the University of Alabama (Birmingham, USA). “Although not directly measured, I feel it contributes to faster graft placement and increased operative speed.”

Related Links:

Cook Medical
University of Alabama 
 


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.